Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |